SHANGHAI, Nov. 27, 2021 /PRNewswire/ Asclepius Meditec ("the Company"), the organizer of the conference, is pleased to announce that five academicians of the Chinese Academy of Engineering
HANNOVER (dpa-AFX) - Die NordLB hat Carl Zeiss Meditec nach Zahlen von Kaufen auf Halten abgestuft, das Kursziel aber von 172 auf 192 Euro angehoben. Der Technologiekonzern habe seine erfreuliche Entwicklung im dritten Geschäftsquartal fortgesetzt und den Jahresausblick angehoben, schrieb An.
BSN Watchlist: publity mit 20 Prozent Tagesplus Die aktuell längste Serie: Carl Zeiss Meditec 7 Tagen Plus in Folge Performance: 6.77% - die Serie dieses Jahr: DWS Group 13 Tage 12.08%. Tagesgewinner war am Mittwoch
Carl Zeiss Meditec Q1 Profit Rises
JENA (dpa-AFX) - Carl Zeiss Meditec AG (CZMWF.PK) reported first quarter earnings per share of 0.52 euros compared to 0.43 euros, a year ago. Earnings before interest and taxes (EBIT) increased to 73.4 million euros from 56.8 million euros. The company noted that its EBIT benefitted in part from lower sales and marketing expenses. Also, EBIT included a one-time gain from the sale of a property in the amount of around 2.4 million euros.
Fist quarter revenue was 368.9 million euros, a decline of 0.2%. After adjustment for currency effects, revenue was up 2.6%.
Carl Zeiss Meditec AG will publish full results for the first quarter 2020/21 on February 8, 2021.